MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT01085331 · TERMINATED
Trial details
- NCT number
- NCT01085331
- Sponsor
- EMD Serono
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.